EN
FR

Image-guided therapy

Interventional imaging systems, smart devices, software and services

Image-guided therapy

Interventional imaging systems, smart devices, software and services

Image-guided therapy

Interventional imaging systems, smart devices, software and services

    Image-guided therapy portfolio

    See clearly. Treat optimally.

    Every day you navigate some of life’s most challenging situations amidst the complexities of modern healthcare. Your work inspires us to develop more seamless solutions – to help you decide, guide, treat, and then confirm the right care, for every patient, in real time.

    Today, the Philips portfolio of image-guided therapy (IGT) solutions uniquely integrates best in class imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment for even the most complex procedures.

    What’s next? More meaningful innovation for more interventional procedures, and continuing support for you with evidence-based technologies to simplify workflows, enhance patient care and reduce costs.

    Together, we make life better.

    The next leap in lab integration: Philips Azurion, an interventional suite guided by you


    With the next generation of our Azurion platform you can control compatible applications for diverse interventional procedures from one touch screen module at table side, to support fast, informed decisions.

    Faster stroke treatment. Learn more about Direct to Angio Suite workflow.


    When it comes to acute stroke, everyone deserves the best care. Today, more patients can benefit from mechanical thrombectomy through changed guidelines*, which widen the time window for endovascular treatment.

    We are always interested in engaging with you.

    Let us know how we can help.

    1
    Select your area of interest
    2
    Contact details

    * View guidelines here: www.philips.com/dtas

    You are about to visit a Philips global content page

    Continue

    You are about to visit a Philips global content page

    Continue

    Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.